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Biocatalysis and Process
Integration in the Synthesis of
Semi-synthetic Antibiotics
nates of the native wild-type apoenzyme
(fromH. Holden, U. Wisconsin) and mod-
eling of important features at the active
site suggest critical attributes that can be
further modified to continue the rational
design of this enzyme for bioremediation
of pesticide contaminants and CW A stock-
piles. OPH is one of the few enzymes
which has been shown to be capable of
hydrolyzing the P-S bond of various OP
pesticides; however, it possesses a wide
range of catalytic rates (0.0067-167 S-I).
Nonetheless, it has been possible to en-
hance the unique P-S bond hydrolysis of
this enzyme by selecting specific changes
in the amino acids bordering the active
site. Thus, it appears that the capacity for
further improvement is remarkable, and
the opportunity for a variety ofbiotechni-
Aile Bruggink*
Introduction
The fine chemical industry is one of
the industry segments where the impact of
biocatalysis is felt most profoundly. Pos-
sible explanations are [1][2]:
- the need to replace traditional, stoichio-
metric processes in order to improve
the product to waste ratio,
the failure to translate chemocatalytic
processes from petrochemicals to fine
chemicals,
- the ready acceptance of enzymes by
the organic chemist as part of his tool-
box, whereas organic chemistry is still
the dominating discipline in fine chem-
ical industry [3],
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cal applications from the development of
transgenic soil fungi and plants to whole
cell hydrolysis in slurry-bed bioreacter
systems to air stream purging and devel-
opment of neurotoxin-specific bioreac-
tors (see references) is quite pronounced.
[I) B. Xu, l.R. Wild, C.M. Kenerley, J. Fer-
mentation and Bioengineering 1996, 81,
473.
[2] J.K. Grimsley, V.K. Ratogi, J.R. Wild,
'Biological Systems for the Detoxification
of Organophosphorus Neurotoxins: Poten-
tial for Environmental Remediation Appli-
cations', in 'Bioremediation: Principles and
Practice', Eds. S.K. Sikdar and R.L. Irvine,
Technomic Publishing Co. Inc., 1996, in
press.
[3] E.!. Rainina, A.L. Simonian, E.N. EIre-
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- the low entry barrier, i.e. low invest-
ments, for new technologies in this
small scale industry, facilitated by the
fact that fine chemical companies be-
come increasingly part oflarger indus-
trial conglomerates.
Synthesis of Semi-synthetic Antibiotics
The industrial production of semi-syn-
thetic antibiotics, with a history of some
30 years, is an outstanding example of the
development of biocatalysis. Cefalexin,
with an annual consumption of almost
2000 t, the largest cephalosporin on the
world market, serves as a useful illustra-
tion. The original synthesis (see Fig.) start-
ing from benzaldehyde and fermentation
of penicillin G was a ten-step process
employing stoichiometric chemistry only
and causing a waste stream of 30-40 kg
per kg of end product. Often 4-6 different
companies were involved to serve the chain
from basic raw materials to bulk drug;
nowadays one or two companies cover the
full production column.
menea, S.D. Varfolomeyev, l.R. Wild, Bi-
osensors and Bioelectronics] 996, in press.
[4] K. Lai, N.J. Stolowich, Arch. Biochem.
Biophys. 1995,318,59.
[5] F. Yang, J.R. Wild, A.L. Russell, Biotecll-
nol. Prog. 1995, 11, 71.
[6] F.c.G. Hoskin, J.E. Walker, W-D. Dett-
bam,J.R. Wild, Biochem. Pharnwcol.1995,
49, 711.
[7] lE. Kolakowski, J.J. DeFrank, K. Lai, l.R.
Wild, 1996, submitted for publication.
[8] KJ. Dave, L. Phillips, VA Luckow, J.R.
Wild, Biotech. and Appl. Biochem. ]994,
19,271.
[9] K. Lai, K.I. Dave, J.R. Wild, J. Bioi. Chem.
1994,269, 16579.
[10] L. Pei, G. Omburo, W.O. McGuinn,. I.
Petrikovics, K.J. Dave, F.M. Raushel, J.R.
Wild, J.R. DeLoach, l.L. Way, Toxicol.
Appl. Pharmacal. ]994, 124,296.
[II] K.I. Dave, C.E. Miller, J.R. Wild, Clzem.-
Bioi. Interact. 1993, 87, 55.
The Chemferm Process
In the Chemferm process (Fig.) only
six steps are needed, whereby biocatalysis
is involved in three of them [4]; a major
improvement through the eyes of the or-
ganicchemist [5]. However, when itcomes
to the design of the production plant for
the final coupling step, the engineers are
faced with an equilibrium process requir-
ing recycle of starting materials and han-
dling of many solids:
- crystallization and isolation of the de-
sired cefalexin,
- crystallization and recovery of excess
7-ADCA (= 7-aminodeacetoxycepha-
losporanic acid),
- crystallization and isolation of phe-
nylglycine from undesired hydrolysis
of both end product and side-chain
precursor.
So far, in our developments at Chem-
ferm, the environment has been the main
winner. Only aqueous waste streams con-
taining some simple inorganic salts are
produced, whereas the traditional process
releases methylene chloride and other sol-
vents and needs stoichiometric amounts
of silylating agents, Dane-salt-protected
side chains and acylating promotors (such
as pivaloyl chloride) which all end up as
waste.
The NOVO Process
An alternative process was developed
by NOVO, acquired and further improved
by Chemferm. Using /3-naphthol as com-
plexing agent, which surprisingly is com-
patible with the enzymatic condensation
conditions, an almost quantitative yield of
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NEW ROUTE TO CEFALEXIN WITH FOUR FEWER STEPS AND MORE ENZYMATIC
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by eliminating organic waste. The overall
production process, however, is more com-
plicated, because of several recycle streams
and a large number of solids to be handled.
A better understanding of enzyme ac-
tion on a molecular level and a rational
design of improved biocatalysts (includ-
ing immobilization) are needed to reach
more ideal processes where recycles are
eliminated. Also, more adequate down-
stream processing including, e.g. selec-
tive absorption of end products through
modern molecular recognition techniques,
are required to achieve feasable processes
at plant scale.
the 2: I cefalexin-l3-naphthol complex is
obtained [6].
Again, from a synthetic point of view,
an excellent process, but once more the
chemical engineers have to solve a few
tough separation and recycle problems:
- separation of phenylglycine from the
cefalexin-,B-naphthol complex,
- isolation of cefalexin, free of I3-naph-
thol, from the complex,
- isolation and recycling of ,B-naphthol.
All this can be done, but a very careful
optimization of all process parameters is
required and extra investments in equip-
ment for handling solids can not be avoid-
ed.
Conclusions
Integration of biocatalysis in the syn-
thesis of s.s. antibiotics, i.e. cefalexin,
greatly reduces the number of steps and is
of considerable benefit to the environment
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